A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

计划入组 19 人 · 首次发布于 2014 年 9 月 12 日

Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers

计划入组 50 人 · 首次发布于 2019 年 1 月 2 日

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

计划入组 168 人 · 首次发布于 2023 年 5 月 6 日

PET-flourescence biomodal imaging agent (ER-positive breast cancer)

ER-67880

ER-260891

ASSO DE RECHERCHE CANCERS GYNECOLOGIQUES

France

Arvinas

United States

Veru Inc

United States

Shuttle Pharmaceuticals Secures $4.5 Million to Advance Ropidoxuridine Clinical Trials

Megestrol Acetate Shows Dual Benefits in ER-Positive Breast Cancer Treatment

Camizestrant Improves Progression-Free Survival in Advanced ER-Positive Breast Cancer